Vaxcyte's total assets for Q2 2026 were $3.14B, a decrease of -6.28% from the previous quarter. DE:5VA total liabilities were $380.21M for the fiscal quarter, a 7.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.